Edward J. Sitar is CFO at INNOVATE BIOPHARMACEUTICALS, INC. (NMTR). They have made 8 open-market trades across 3 companies since 2014, most recently 2023-04-15.
CIK 0001603489
7 open-market purchases totalling $136K since 2014, against 1 sale. Across 7 scored buys the stock is up 2.8% at ninety days, and 1.2 points ahead of the S&P over the same stretch.
7 scored purchases · one row per filing · discretionary only
| 7d | 30d | 90d | |
|---|---|---|---|
| Accuracy | 29% | 71% | 57% |
| Avg Move | -15.9% | +5.7% | +2.8% |
| Alpha | -13.9% | +4.4% | +1.2% |
| Scored | 7 | 7 | 7 |
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| TMBR | BUY | 2021-11-23 | 2021-11-24 | $0.46 | $7K | -12.5% | -7.9% | -34.3% |
| NMTR | BUY | 2021-09-14 | 2021-09-15 | $1.22 | $18K | +10.4% | +3.2% | -32.0% |
| NMTR | BUY | 2021-04-05 | 2021-04-06 | $1.00 | $50K | -12.0% | -6.4% | -14.4% |
| NMTR | BUY | 2020-12-15 | 2020-12-17 | $0.65 | $40K | +4.3% | +49.1% | +98.4% |
| CGIX | SELL | 2016-11-16 | 2016-11-16 | $1.56 | $5K | -3.0% | -15.2% | +36.4% |
| CGIX | BUY | 2015-03-16 | 2015-03-18 | $6.99 | $7K | -33.9% | +0.6% | +0.6% |
| CGIX | BUY | 2014-12-12 | 2014-12-15 | $6.26 | $3K | -33.9% | +0.6% | +0.6% |
| CGIX | BUY | 2014-05-21 | 2014-05-22 | $10.67 | $11K | -33.9% | +0.6% | +0.6% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.